TY  - JOUR
AU  - Andrés Guerrero, Vanesa
AU  - Perucho González, Lucía
AU  - García Feijoo, Julián
AU  - Morales Fernández, Laura
AU  - Sáenz Francés, Federico
AU  - Herrero Vanrell, María Del Rocío
AU  - Pablo Júlvez, Luis
AU  - Polo Llorens, Vicente
AU  - Martínez De La Casa Fernández-Borrella, José María
AU  - Konstas, Anastasios Georgios P.
DA  - Received: October 17, 2016 / Published online: December 20, 2016.
PY  - 2017
DO  - 10.1007/s12325-016-0461-z
SN  - 0741-238X
UR  - https://hdl.handle.net/20.500.14352/18063
T2  - Advances in Therapy
AB  - The approval of one of the first anti-vascular endothelial growth factor (VEGF) agents for the treatment of neovascular age-related macular degeneration one decade ago marked the beginning of a new era in the management of several sight-threatening...
LA  - eng
M2  - 378
PB  - Springer Healthcare
KW  - Angiogénesis
KW  - Aflibercept
KW  - Bevacizumab
KW  - Glaucoma filtration surgery
KW  - Neovascular glaucoma
KW  - Ranibizumab
KW  - VEGF
KW  - Wound modulation
TI  - Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma
TY  - journal article
VL  - 34
ER  -